title: Neutral glycolipid composition of primary human brain tumors.
abstract: Neutral glycolipids (NGL) were isolated and quantitated in 98 primary human brain tumors; 19 low grade astrocytomas (LGA), 12 anaplastic astrocytomas (AA), 37 high grade astrocytomas (HGA), 18 oligodendroglial tumors, and 12 primitive neuroectodermal tumors (PNET). In 38 of these, the nature of the hexose in the cerebroside was determined using immunothin-layer chromatographic techniques. Galactosylceramide (GalCer) was the major ceramide monohexoside (CMH), and glucosylcerebroside never comprised more than 6% of this fraction in any tumor type. Furthermore, there was no correlation between the proportion of glucosylcerebroside and histological diagnosis. AA had the most characteristic neutral glycolipid pattern, with high levels of total lipid, total neutral glycolipid, CMH, and ceramide dihexoside (CDH) but low water contents. Consistent with this glycolipid composition is the finding that AA usually had neither ceramide trihexoside (CTH) nor globoside. Oligodendrogliomas were somewhat similar to AA in having high levels of CMH and infrequently having CTH or globoside. However, oligodendrogliomas had low water and total lipid contents. PNET had low levels of total lipid, total NGL, and CMH, but frequently contained CTH and globoside. LGA had high water contents but low levels of total lipid and CMH. HGA tended to have intermediate levels of almost all constituents analyzed, probably reflecting the pronounced cellular heterogeneity of these tumors. The frequent presence of GalCer in astrocytomas raises the possibility that some of these contain a population of cells that are related to the oligodendroglial lineage. However, the low amounts of GalCer and infrequent presence of sulfatide in PNET is consistent with their lack of differentiation toward oligodendrocytes. It will be of interest to determine if the neutral glycolipid patterns reported here will correlate with patient survival and be of prognostic significance.
authors.affiliation: Division of Neuropathology, Ohio State University, Columbus 43210.
authors.forename: L P
authors.initials: LP
authors.lastname: Singh
authors.forename: D K
authors.initials: DK
authors.lastname: Pearl
authors.forename: T K
authors.initials: TK
authors.lastname: Franklin
authors.forename: P M
authors.initials: PM
authors.lastname: Spring
authors.forename: B W
authors.initials: BW
authors.lastname: Scheithauer
authors.forename: S W
authors.initials: SW
authors.lastname: Coons
authors.forename: P C
authors.initials: PC
authors.lastname: Johnson
authors.forename: S E
authors.initials: SE
authors.lastname: Pfeiffer
authors.forename: J
authors.initials: J
authors.lastname: Li
authors.forename: J C
authors.initials: JC
authors.lastname: Knott
mesh_terms: D001254:Astrocytoma / Q000737:chemistry* / Q000473:pathology / Q000601:surgery; D001932:Brain Neoplasms / Q000737:chemistry* / Q000473:pathology / Q000601:surgery; D002518:Ceramides / Q000032:analysis; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D002855:Chromatography, Thin Layer / Q000379:methods; D005910:Glioma / Q000737:chemistry / Q000473:pathology / Q000601:surgery; D006017:Glycolipids / Q000032:analysis*; D006801:Humans; D018242:Neuroectodermal Tumors, Primitive / Q000737:chemistry* / Q000473:pathology; D013433:Sulfoglycosphingolipids / Q000032:analysis
chemical_list: D002518:Ceramides; D006017:Glycolipids; D013433:Sulfoglycosphingolipids